Generic placeholder image

Current Cancer Drug Targets

Editor-in-Chief

ISSN (Print): 1568-0096
ISSN (Online): 1873-5576

Perspective

Current Perspectives in Ultra-sensitive Detection of Cancer-specific Biomarkers and Therapeutic Targets

Author(s): Lyudmila V. Savvateeva, Evgeni Yu. Zernii and Andrey A. Zamyatnin*

Volume 23, Issue 11, 2023

Published on: 16 May, 2023

Page: [829 - 833] Pages: 5

DOI: 10.2174/1568009623666230420152113

conference banner
Next »
[1]
Freudenberg, J.A.; Bembas, K.; Greene, M.I.; Zhang, H. Noninvasive, ultra-sensitive, high-throughput assays to quantify rare biomarkers in the blood. Methods, 2008, 46(1), 33-38.
[http://dx.doi.org/10.1016/j.ymeth.2008.05.005] [PMID: 18573345]
[2]
Zhang, H.; Cheng, X.; Richter, M.; Greene, M.I. A sensitive and high-throughput assay to detect low-abundance proteins in serum. Nat. Med., 2006, 12(4), 473-477.
[http://dx.doi.org/10.1038/nm1378] [PMID: 16532003]
[3]
Kang, J.; Jang, H.; Yeom, G.; Kim, M.G. Ultrasensitive detection platform of disease biomarkers based on recombinase polymerase amplification with H-Sandwich aptamers. Anal. Chem., 2021, 93(2), 992-1000.
[http://dx.doi.org/10.1021/acs.analchem.0c03822] [PMID: 33296598]
[4]
Chan, HN; Xu, D; Ho, SL; He, D; Wong, MS; Li, HW. Highly sensitive quantification of Alzheimer's disease biomarkers by aptamer-assisted amplification. Theranostics, 2019, 9(10), 2939-2949.
[http://dx.doi.org/10.7150/thno.29232]
[5]
Morozova, T.Y.; Morozov, V.N. Force differentiation in recognition of cross-reactive antigens by magnetic beads. Anal. Biochem., 2008, 374(2), 263-271.
[http://dx.doi.org/10.1016/j.ab.2007.12.007] [PMID: 18191032]
[6]
Shlyapnikov, Y.M.; Kanev, I.L.; Shlyapnikova, E.A. Rapid ultrasensitive Gel-Free immunoblotting with magnetic labels. Anal. Chem., 2020, 92(5), 4146-4153.
[http://dx.doi.org/10.1021/acs.analchem.0c00314] [PMID: 32023039]
[7]
Shlyapnikov, Y.M.; Shlyapnikova, E.A.; Simonova, M.A.; Shepelyakovskaya, A.O.; Brovko, F.A.; Komaleva, R.L.; Grishin, E.V.; Morozov, V.N. Rapid simultaneous ultrasensitive immunodetection of five bacterial toxins. Anal. Chem., 2012, 84(13), 5596-5603.
[http://dx.doi.org/10.1021/ac300567f] [PMID: 22724559]
[8]
Morozov, V.N.; Groves, S.; Turell, M.J.; Bailey, C. Three minuteslong electrophoretically assisted zeptomolar microfluidic immunoassay with magnetic-beads detection. J. Am. Chem. Soc., 2007, 129(42), 12628-12629.
[http://dx.doi.org/10.1021/ja075069m] [PMID: 17902669]
[9]
Shlyapnikov, Y.M.; Malakhova, E.A.; Vinarov, A.Z.; Potoldykova, N.V.; Vladimirov, V.I.; Zernii, E.Y.; Zamyatnin, A.A., Jr; Shlyapnikova, E.A. Cancer-retina antigens in the urine of bladder and prostate cancer patients. Biochemistry, 2022, 87(11), 1268-1276.
[http://dx.doi.org/10.1134/S0006297922110062] [PMID: 36509724]
[10]
Liu, L.; Wu, S.; Jing, F.; Zhou, H.; Jia, C.; Li, G.; Cong, H.; Jin, Q.; Zhao, J. Bead-based microarray immunoassay for lung cancer biomarkers using quantum dots as labels. Biosens. Bioelectron., 2016, 80, 300-306.
[http://dx.doi.org/10.1016/j.bios.2016.01.084] [PMID: 26852198]
[11]
Mehdorn, A.S.; Gemoll, T.; Busch, H.; Kern, K.; Beckinger, S.; Daunke, T.; Kahlert, C.; Uzunoglu, F.G.; Hendricks, A.; Buertin, F.; Wittel, U.A.; Sunami, Y.; Röcken, C.; Becker, T.; Sebens, S. Biomarkers in liquid biopsies for prediction of early liver metastases in pancreatic cancer. Cancers, 2022, 14(19), 4605.
[http://dx.doi.org/10.3390/cancers14194605] [PMID: 36230528]
[12]
Li, W. Plasma protein biomarker measurements. Figshare, 2020. Available from: https://figshare.com/articles/dataset/Plasma_ protein_biomarker_measurements/7642268/1
[13]
Ura, B.; Capaci, V.; Aloisio, M.; Di Lorenzo, G.; Romano, F.; Ricci, G.; Monasta, L. A targeted proteomics approach for screening serum biomarkers observed in the early stage of Type I endometrial cancer. Biomedicines, 2022, 10(8), 1857.
[http://dx.doi.org/10.3390/biomedicines10081857] [PMID: 36009404]
[14]
Ivanov, YD; Romanova, TS; Malsagova, KA. Use of silicon nanowire sensors for early cancer diagnosis. Molecules, 2021, 26(12), 3734.
[http://dx.doi.org/10.3390/molecules26123734]
[15]
Huang, Q.; Li, N.; Zhang, H.; Che, C.; Sun, F.; Xiong, Y.; Canady, T.D.; Cunningham, B.T. Critical Review: Digital resolution biomolecular sensing for diagnostics and life science research. Lab Chip, 2020, 20(16), 2816-2840.
[http://dx.doi.org/10.1039/D0LC00506A] [PMID: 32700698]
[16]
Nimse, S.B.; Sonawane, M.D.; Song, K.S.; Kim, T. Biomarker detection technologies and future directions. Analyst, 2016, 141(3), 740-755.
[http://dx.doi.org/10.1039/C5AN01790D] [PMID: 26583164]
[17]
Li, Q.; Brown, J.B.; Huang, H.; Bickel, P.J. Measuring reproducibility of high-throughput experiments. Ann. Appl. Stat., 2011, 5(3), 1752-1779.
[http://dx.doi.org/10.1214/11-AOAS466]
[18]
Bazhin, A.V.; Schadendorf, D.; Philippov, P.P.; Eichmüller, S.B. Recoverin as a cancer-retina antigen. Cancer Immunol. Immunother., 2006, 56(1), 110-116.
[http://dx.doi.org/10.1007/s00262-006-0132-z] [PMID: 16444517]
[19]
Maeda, A.; Ohguro, H.; Maeda, T.; Wada, I.; Sato, N.; Kuroki, Y.; Nakagawa, T. Aberrant expression of photoreceptor-specific calcium-binding protein (recoverin) in cancer cell lines. Cancer Res., 2000, 60(7), 1914-1920.
[PMID: 10766180]
[20]
Matsuo, S.; Ohguro, H.; Ohguro, I.; Nakazawa, M. Clinicopathological roles of aberrantly expressed recoverin in malignant tumor cells. Ophthalmic Res., 2010, 43(3), 139-144.
[http://dx.doi.org/10.1159/000253486] [PMID: 19887879]
[21]
Golovastova, M.O.; Tsoy, L.V.; Bocharnikova, A.V.; Korolev, D.O.; Gancharova, O.S.; Alekseeva, E.A.; Kuznetsova, E.B.; Savvateeva, L.V.; Skorikova, E.E.; Strelnikov, V.V.; Varshavsky, V.A.; Vinarov, A.Z.; Nikolenko, V.N.; Glybochko, P.V.; Zernii, E.Y.; Zamyatnin, A.A., Jr; Bazhin, A.V.; Philippov, P.P. The cancer-retina antigen recoverin as a potential biomarker for renal tumors. Tumour Biol., 2016, 37(7), 9899-9907.
[http://dx.doi.org/10.1007/s13277-016-4885-5] [PMID: 26813565]
[22]
Bazhin, A.V.; Schadendorf, D.; Willner, N.; De Smet, C.; Heinzelmann, A.; Tikhomirova, N.K.; Umansky, V.; Philippov, P.P.; Eichmüller, S.B. Photoreceptor proteins as cancer-retina antigens. Int. J. Cancer, 2007, 120(6), 1268-1276.
[http://dx.doi.org/10.1002/ijc.22458] [PMID: 17187367]
[23]
Bazhin, AV; Dalke, C; Willner, N. Cancer-retina antigens as potential paraneoplastic antigens in melanoma-associated retinopathy. Int J Cancer, 2009, 124(1), 140-9.
[http://dx.doi.org/10.1002/ijc.23909]
[24]
Golovastova, M.O.; Bazhin, A.V.; Philippov, P.P. Cancer-retina antigens — A new group of tumor antigens. Biochemistry, 2014, 79(8), 733-739.
[http://dx.doi.org/10.1134/S000629791408001X] [PMID: 25365483]
[25]
Golovastova, M.O.; Korolev, D.O.; Tsoy, L.V.; Varshavsky, V.A.; Xu, W.H.; Vinarov, A.Z.; Zernii, E.Y.; Philippov, P.P.; Zamyatnin, A.A., Jr. Biomarkers of renal tumors: The current state and clinical perspectives. Curr. Urol. Rep., 2017, 18(1), 3.
[http://dx.doi.org/10.1007/s11934-017-0655-1] [PMID: 28110463]
[26]
Baldin, A.V.; Grishina, A.N.; Korolev, D.O.; Kuznetsova, E.B.; Golovastova, M.O.; Kalpinskiy, A.S.; Alekseev, B.Y.; Kaprin, A.D.; Zinchenko, D.V.; Savvateeva, L.V.; Varshavsky, V.A.; Zernii, E.Y.; Vinarov, A.Z.; Bazhin, A.V.; Philippov, P.P.; Zamyatnin, A.A., Jr. Autoantibody against arrestin-1 as a potential biomarker of renal cell carcinoma. Biochimie, 2019, 157, 26-37.
[http://dx.doi.org/10.1016/j.biochi.2018.10.019] [PMID: 30389514]
[27]
Shlyapnikov, Y.M.; Malakhova, E.A.; Potoldykova, N.V.; Svetocheva, Y.A.; Vinarov, A.Z.; Zinchenko, D.V.; Zernii, E.Y.; Zamyatnin, A.A., Jr; Shlyapnikova, E.A. Non-invasive diagnostics of renal cell carcinoma using ultrasensitive immunodetection of Cancer-Retina antigens. Biochemistry, 2022, 87(7), 658-666.
[http://dx.doi.org/10.1134/S0006297922070070] [PMID: 36154884]
[28]
Zhao, Y; Baldin, AV; Isayev, O; Werner, J; Zamyatnin, AA, Jr.; Bazhin, AV. Cancer vaccines: Antigen selection strategy. Vaccines, 2021, 9(2), 85.
[http://dx.doi.org/10.3390/vaccines9020085]
[29]
Zhao, Y; Baldin, AV; Isayev, O; Werner, J; Zamyatnin, AA, Jr.; Bazhin, AV. Cancer vaccines: Antigen selection strategy. Vaccines, 2021, 9(2), 85.
[http://dx.doi.org/10.3390/vaccines9020085]
[30]
Baldin, A.V.; Zamyatnin, A.A., Jr; Bazhin, A.V.; Xu, W.H.; Savvateeva, L.V. Advances in the development of anticancer HSP-based vaccines. Curr. Med. Chem., 2019, 26(3), 427-445.
[http://dx.doi.org/10.2174/0929867325666180129100015] [PMID: 29376489]

© 2024 Bentham Science Publishers | Privacy Policy